PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance.
Saved in:
| Title: | PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance. |
|---|---|
| Authors: | Pilotto S; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Belluomini L; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Monaca F; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Simbolo M; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.; ARC-NET Applied Research on Cancer Center, University and Hospital Trust of Verona, Verona, Italy., Agostini A; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Mafficini A; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.; ARC-NET Applied Research on Cancer Center, University and Hospital Trust of Verona, Verona, Italy., Golovco S; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.; ARC-NET Applied Research on Cancer Center, University and Hospital Trust of Verona, Verona, Italy., Sperduti I; Biostatistics, IRCCS Regina Elena National Cancer Institute, Rome, Lazio, Italy., Vita E; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy., Stefani A; Università Cattolica del Sacro Cuore, Rome, Italy., Carbone C; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Piro G; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Ferrara MG; Università Cattolica del Sacro Cuore, Rome, Italy.; Thermo Fisher Scientific, Waltham, MA, USA., Lococo F; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Ludovini V; Division of Medical Oncology, Santa Maria della Misericordia Hospital, University of Perugia, Perugia, Italy., Chiari R; UOC Oncologia, AST Pesaro Urbino, Pesaro, Italy., Novello S; Thoracic Oncology Unit, San Luigi Hospital, University of Turin, Orbassano, Italy., Corbo V; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.; ARC-NET Applied Research on Cancer Center, University and Hospital Trust of Verona, Verona, Italy., Milella M; Section of Innovation Biomedicine-Oncology Area, Department of Engineering for Innovation Medicine, University of Verona School of Medicine and Verona University Hospital Trust, Verona, Italy., Scarpa A; Department of Diagnostics and Public Health, University and Hospital Trust of Verona, Verona, Italy.; ARC-NET Applied Research on Cancer Center, University and Hospital Trust of Verona, Verona, Italy., Tortora G; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Rome, Italy.; Dipartimento di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Rome, Italy., Bria E; Comprehensive Cancer Center, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Largo Francesco Vito, 1, Rome 00168, Italy.; Università Cattolica del Sacro Cuore, Rome, Italy Medical Oncology, Ospedale Isola Tiberina-Gemelli Isola, Rome, Italy. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2025 Nov 07; Vol. 17, pp. 17588359251370510. Date of Electronic Publication: 2025 Nov 07 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359251370510 |